Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Aclaris Therapeutics, Inc.

Clinical trials sponsored by Aclaris Therapeutics, Inc., explained in plain language.

Aclaris Therapeutics, Inc. ACRS NASDAQ

A biopharmaceutical company focused on dermatology and immunology.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1 Completed 2

New eczema drug shows promise in Mid-Stage trial

Disease control Ongoing

This study tests whether ATI-045 can safely reduce eczema symptoms like redness, itching, and skin patches in people with moderate-to-severe disease. About 110 adults who haven't had success with topical treatments will receive either the drug or a placebo. The main goal is to se…

Phase: PHASE2 • Sponsor: Aclaris Therapeutics, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:00 UTC